IMRN: Immuron Inc Company Aggregate Debts

Symbol and logo of brand immuron.com.au (IMRN)

The stability of Australia's raw material base ensures the uninterrupted production of Immuron Limited. Total debt levels confirm this resilience, with 0.00 serving as the current metric. Unique antibody extraction patents provide a defensive moat for the business. The company is currently scaling the distribution of over-the-counter gastrointestinal products, expanding its pharmacy networks across Europe, the US, and Australia.

Immuron Ltd - IMRN Company Debts (period 07/04/2022 - 10/27/2026)

Analytical breakdowns and data insights for company Immuron Limited (IMRN)

- price and consensus price forecast:
Price Performance Chart immuron.com.au|IMRN - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Immuron Inc|IMRN - Total Company Value
- book capitalization data:
Accounting Value of a Share Immuron|IMRN - Company Book Value|Market Cap to Net Assets Ratio immuron.com.au|IMRN - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Immuron Limited|IMRN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital immuron.com.au|IMRN - Company Aggregate Debts|Debt to Net Assets Immuron Inc
Fundamental valuation:IMRN Immuron Ltd
Original product of Immuron

Investors view Immuron Limited (IMRN) as a high-risk asset, where the total amount of loans and bonds determines financial stability given its narrow specialization in colostrum-based products. When analyzing current debt obligations, the aggregate volume of borrowed capital must be evaluated, as the stability of this metric against the backdrop of contracts with the US Army confirms the solvency of this biopharmaceutical company.

Key competitors

Aggregate Debt Obligations Phathom (PHAT)|Company Aggregate Debts TERN (Terns Pharmaceuticals)|Ironwood Pharma - Company Aggregate Debts|Company Debts Curanex (CURX)|EVOK: Aggregate Debt Obligations|ENTO (enterothera.com) - Company Debts|RedHill Biopharma Ltd. (RDHL) - Company Total Debt|PALI (Palisade Bio) - Company Aggregate Debts|Company Aggregate Debts jaguar.health (JAGX)|Biora Therapeutics, Inc. (BIOR) - Company Total Debt|Aggregate Debt Obligations Morphic Therapeutic (MORF)